組織蛋白酶L(CTSL)多克隆抗體
Polyclonal Antibody to Cathepsin L (CTSL)
CTSL1; CATL; CTS-L; MEP; Cathepsin L1; Major excreted protein
- 編號PAA306Po01
- 物種Sus scrofa; Porcine (Pig，豬)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPA306Po01-組織蛋白酶L(CTSL)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.38mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應用IHC
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 680¥ 1588¥ 2268¥ 5670¥ 22680
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P;
Sample: Rat Kidney Tissue
Primary Ab: 10μg/ml Rabbit Anti-Porcine CTSL Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Rat Placenta Tissue
Primary Ab: 10μg/ml Rabbit Anti-Porcine CTSL Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Rat Spinal cord Tissue
Primary Ab: 10μg/ml Rabbit Anti-Porcine CTSL Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Figure. Western Blot; Sample: Recombinant CTSL, Porcine.
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對CTSL的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CTSL。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA306Po01 | 組織蛋白酶L(CTSL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA306Po01 | 組織蛋白酶L(CTSL)多克隆抗體 | IHC |
| LAA306Po81 | 組織蛋白酶L(CTSL)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA306Po71 | 組織蛋白酶L(CTSL)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| Hypertension | Identification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage. [Ahajournals: source] |
| The Journal of International Medical Research | Plasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease[Ingenta: art00021] |
| Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery[Pubmed:24534452] |
| International Journal of Molecular Sciences | A New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor[Pubmed: 31052424] |
| EMBO Molecular Medicine | Immune‐mediated ECM depletion improves tumour perfusion and payload delivery[Pubmed: 31709774] |
| Cardiovasc Res | Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size[34132807] |